- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05458687
Traditional Chinese Medicine for Complications in Critically Ill Patients
Traditional Chinese Medicine for Complications in Critically Ill Patients: a Randomized Control Trial
Study Overview
Status
Conditions
Detailed Description
Introduction: Intensive care unit is a special department in the health care facility. Although with highly development of modern medicine nowadays, the average mortality rate in Intensive care unit is still around 7 to 20 %. There are a few tricky problems that intensivists and intensive care nurses faced very often, including intensive care unit delirium, arrythmia and poor digestion problem that will all affect the mortality and morbidity rate of critical care patients. Traditional Chinese Medicine can possibly provide a series of interventions that can alleviate those conditions.
Methods: A randomized control trial will examine the effect of traditional Chinese Medicine interventions vs. routine intensive care unit care. The patients will be randomly divided 1:1 into one of two groups. A total of 80 intensive care patient will have to meet the following criteria: age 20-90, two or less inotropic medicine use. Interventions such as: Chinese herbal medicine decoction, acupuncture, laser acupuncture, Chinese Tuina massage, herbal medicinal cake applied on acupoint, health education and diet education, will be given based on the patients needs and Traditional Chinese Medicine doctor decision. The main outcomes will be the incidence of arrythmia, delirium, and poor digestion and the severity of pain. The investigators will also record intensive care unit mortality, intensive care unit stays and hospital days.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yu-Chen Lee, Ph.D.
- Phone Number: 4564 886-4-22052121
- Email: d5167@mail.cmuh.org.tw
Study Locations
-
-
-
Taichung, Taiwan, 404
- Recruiting
- China Medical University Hospital
-
Contact:
- Yu-Chen Lee, Ph.D.
- Phone Number: +886-975-682-023
- Email: d5167@mail.cmuh.org.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 20-90
- newly intensive care unit admission (<48 hours)
- Two or less inotropic medicine prescribed
Exclusion Criteria:
- Clinically unstable: receiving more than inotropic agents.
- Coagulopathy: Prolong Prothrombin Time、activated Partial Thromboplastin Time more than 4 times
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intervention group
|
|
No Intervention: control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The main outcomes will be the incidence of arrhythmia, delirium, and poor digestion and the severity of pain.
Time Frame: ICDSC、RASS、BPS record by everyday.
|
For delirium use the Intensive Care Delirium Screening Checklist (ICDSC) score of:0~8. And Richmond Agitation-Sedation Scale (RASS) score of: -5~+4. For pain use the Behavioral pain scale(BPS) score of:3~12. |
ICDSC、RASS、BPS record by everyday.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMUH111-REC3-064
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critically Ill Patients
-
University Hospital, RouenCompletedSedated Patients | Critically Ill Patients Under Mechanical VentilationFrance
-
The Cleveland ClinicCompletedCritically Ill Patients | Cardiovascular Surgery Telemetry PatientsUnited States
-
University of PittsburghNational Institute on Aging (NIA)CompletedPhysician-Family Communication in Intensive Care Units | Surrogate Decision-making for Critically Ill Patients | Critically Ill Intensive Care Unit PatientsUnited States
-
Wuhan Union Hospital, ChinaRecruiting
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompletedCritically Ill PatientsBelgium
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
-
University of ZurichIntuitive SurgicalUnknown
-
Policlinico HospitalCompletedCritically Ill PatientsItaly
-
Hospital Sao DomingosCompletedCritically Ill PatientsBrazil
Clinical Trials on Chinese herbal medicine decoction、Acupuncture or Laser acupuncture pen treatment、Acupoint Tuina massage、Acupoint application、Nursing/Diet and health education and guidance
-
China Medical University HospitalRecruiting